AnaptysBio
-$0.15 (-0.64%) As of 5:43 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.
About ANAB
AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.
CEO
Hamza Suria
Employees
94
Headquarters
San Diego, California
Founded
2005
ANAB Key Statistics
Market Cap
637.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
233.74K
High Today
$23.77
Low Today
$23.01
Open Price
$23.29
Volume
22.70K
52 Week High
$35.85
52 Week Low
$13.92
Analyst Ratings
43%
of 7 ratings
Buy
42.9%
Hold
42.9%
Sell
14.3%
ANAB Earnings
-$1.20
-$0.34
$0.53
$1.39
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours